Literature DB >> 15179359

Cancer mortality surveillance--United States, 1990-2000.

Sherri L Stewart1, Jessica B King, Trevor D Thompson, Carol Friedman, Phyllis A Wingo.   

Abstract

PROBLEM/CONDITION: Cancer is the second leading cause of death in the United States and is expected to become the leading cause of death within the next decade. Considerable variation exists in cancer mortality between the sexes and among different racial/ethnic populations and geographic locations. The description of mortality data by state, sex, and race/ethnicity is essential for cancer-control researchers to target areas of need and develop programs that reduce the burden of cancer. REPORTING PERIOD COVERED: 1990-2000. DESCRIPTION OF SYSTEM: Mortality data from CDC were used to calculate death rates and trends, categorized by state, sex, and race/ethnicity. Trend analyses for 1990-2000 are presented for all cancer sites combined and for the four leading cancers causing death (lung/bronchus, colorectal, prostate, and breast) categorized by state, sex, and race/ethnicity. Death rates per 100,000 population for the 10 primary cancer sites with the highest age-adjusted rates are also presented for each state and the District of Columbia by sex. For males, the 10 primary sites include lung/bronchus, prostate, colon/rectum, pancreas, leukemia, non-Hodgkin lymphoma, liver/intrahepatic bile duct, esophagus, stomach, and urinary bladder. For females, the 10 primary sites include lung/bronchus, breast, colon/rectum, pancreas, ovary, non-Hodgkin lymphoma, leukemia, brain/other nervous system, uterine corpus, and myeloma.
RESULTS: For 1990-2000, cancer mortality decreased among the majority of racial/ethnic populations and geographic locations in the United States. Statistically significant decreases in mortality among all races combined occurred with lung and bronchus cancer among men (--1.7%/year); colorectal cancer among men and women (--2.0%/year and--1.7%/year, respectively); prostate cancer (--2.6%/year); and female breast cancer (--2.3%/year). For 1990-2000, cancer mortality remained stable among American Indian/Alaska Native populations. Statistically significant increases in lung and bronchus cancer mortality occurred among women of all racial/ethnic backgrounds, except among Asian/Pacific Islanders.
INTERPRETATION: Although cancer remains the second leading cause of death in the United States, the overall declining trend in cancer mortality demonstrates considerable progress in cancer prevention, early detection, and treatment. PUBLIC HEALTH ACTION: More effective tobacco-cessation programs are necessary to reduce lung and bronchus cancer mortality among women and sustain the decrease in lung and bronchus cancer mortality among men. Additional programs that deter smoking initiation among adolescents are essential to ensure future decreases in lung and bronchus cancer mortality. Continued research in primary prevention, screening methods, and therapeutics is needed to further reduce disparities and improve quality of life and survival among all populations.

Entities:  

Mesh:

Year:  2004        PMID: 15179359

Source DB:  PubMed          Journal:  MMWR Surveill Summ        ISSN: 1545-8636


  36 in total

Review 1.  A comparison of the diagnostic performance of systematic versus ultrasound-guided biopsies of prostate cancer.

Authors:  Stijn W T P J Heijmink; Hilco van Moerkerk; Lambertus A L M Kiemeney; J Alfred Witjes; Ferdinand Frauscher; Jelle O Barentsz
Journal:  Eur Radiol       Date:  2006-01-04       Impact factor: 5.315

2.  Disparities in cancer mortality and incidence among American Indians and Alaska Natives in the United States.

Authors:  Mary C White; David K Espey; Judith Swan; Charles L Wiggins; Christie Eheman; Judith S Kaur
Journal:  Am J Public Health       Date:  2014-04-22       Impact factor: 9.308

3.  A link between cold environment and cancer.

Authors:  Ankit Sharma; Harphool Kumar Verma; Savitri Joshi; Mahaveer Singh Panwar; Chandi C Mandal
Journal:  Tumour Biol       Date:  2015-03-04

4.  American Indian Men's Perceptions of Breast Cancer Screening for American Indian Women.

Authors:  Melissa K Filippi; Joseph Pacheco; Aimee S James; Travis Brown; Florence Ndikum-Moffor; Won S Choi; K Allen Greiner; Christine M Daley
Journal:  J Health Dispar Res Pract       Date:  2014

5.  Co-occurrence of mental and physical illness in US Latinos.

Authors:  Alexander N Ortega; Jonathan M Feldman; Glorisa Canino; Kenneth Steinman; Margarita Alegría
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2006-09-29       Impact factor: 4.328

6.  Reducing racial/ethnic disparities in female breast cancer: screening rates and stage at diagnosis.

Authors:  Franco Sassi; Harold S Luft; Edward Guadagnoli
Journal:  Am J Public Health       Date:  2006-10-31       Impact factor: 9.308

7.  Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis.

Authors:  Zhenbang Chen; Lloyd C Trotman; David Shaffer; Hui-Kuan Lin; Zohar A Dotan; Masaru Niki; Jason A Koutcher; Howard I Scher; Thomas Ludwig; William Gerald; Carlos Cordon-Cardo; Pier Paolo Pandolfi
Journal:  Nature       Date:  2005-08-04       Impact factor: 49.962

8.  Diversity in specificity, abundance, and composition of anti-Neu5Gc antibodies in normal humans: potential implications for disease.

Authors:  Vered Padler-Karavani; Hai Yu; Hongzhi Cao; Harshal Chokhawala; Felix Karp; Nissi Varki; Xi Chen; Ajit Varki
Journal:  Glycobiology       Date:  2008-07-31       Impact factor: 4.313

9.  Dietary fat subgroups, zinc, and vegetable components are related to urine F2a-isoprostane concentration, a measure of oxidative stress, in midlife women.

Authors:  Kristin M Tomey; MaryFran R Sowers; Xizhao Li; Daniel S McConnell; Sybil Crawford; Ellen B Gold; Bill Lasley; John F Randolph
Journal:  J Nutr       Date:  2007-11       Impact factor: 4.798

10.  Socioeconomic and racial patterns of colorectal cancer screening among Medicare enrollees in 2000 to 2005.

Authors:  Chyke A Doubeni; Adeyinka O Laiyemo; George Reed; Terry S Field; Robert H Fletcher
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-07-21       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.